What is the third serological marker associated with immune-mediated necrotizing myopathy?

Scand J Rheumatol. 2017 Sep;46(5):416-417. doi: 10.1080/03009742.2016.1258730. Epub 2017 Jan 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • ATPases Associated with Diverse Cellular Activities / immunology*
  • Aged, 80 and over
  • Autoantibodies / blood
  • Autoimmunity / immunology
  • Biomarkers / analysis
  • Biomarkers / blood
  • Biopsy / methods
  • Carrier Proteins / immunology*
  • DNA Helicases / immunology*
  • Female
  • Humans
  • Hydroxymethylglutaryl CoA Reductases / immunology*
  • Immunosuppressive Agents / administration & dosage
  • Mitochondria, Muscle / metabolism
  • Mitochondrial Proteins / immunology*
  • Muscle, Skeletal / pathology*
  • Muscular Diseases* / diagnosis
  • Muscular Diseases* / drug therapy
  • Muscular Diseases* / immunology
  • Muscular Diseases* / physiopathology
  • Necrosis
  • Prednisolone / administration & dosage*
  • Reproducibility of Results
  • Ribonucleosides / administration & dosage*
  • Serologic Tests
  • Signal Recognition Particle / immunology*
  • Treatment Outcome

Substances

  • Autoantibodies
  • Biomarkers
  • Carrier Proteins
  • Immunosuppressive Agents
  • Mitochondrial Proteins
  • Ribonucleosides
  • Signal Recognition Particle
  • mizoribine
  • Prednisolone
  • HMGCR protein, human
  • Hydroxymethylglutaryl CoA Reductases
  • ATPases Associated with Diverse Cellular Activities
  • DNA Helicases
  • RUVBL1 protein, human
  • RUVBL2 protein, human